Medical and healthcare law Books

281 products


  • Law and Healing: A History of a Stormy Marriage

    Manchester University Press Law and Healing: A History of a Stormy Marriage

    2 in stock

    Book SynopsisThis book delves into medico-legal history, travelling back in time to explore English law’s fascinating and often acrimonious relationship with healing and healers.Challenging assumptions that medical law is a recent development, Law and healing traces the regulation of healers from the Church's dominance to legal battles fought among medical practitioners. As well as considering the history of the regulation of healers, this book addresses moral issues such as abortion, bodily sovereignty, and the use of cadavers in research. It highlights how fundamental legal and ethical questions continue to resurface, for example, from controversy in the Renaissance over human dissection to modern-day debates about organ donation. Law and healing provides a colourful but critical account of the longstanding – and often fraught – relationship between two fundamental pillars of human society.Table of ContentsPreface 1 Medico-legal history: why bother?2 Medical brethren3 ‘Unruly brethren’: regulation and reputation4 The bumpy road to the General Medical Council5 Medical litigation6 Human life, common law and Christianity7 Your living body: ‘temple of the soul’8 Reproductive bodies: mothers, midwives and morals9 The not (yet) born child10 Honouring the dead: commodifying the corpsePostscriptIndex

    2 in stock

    £76.50

  • Medicine, Patients and the Law: Seventh Edition

    Manchester University Press Medicine, Patients and the Law: Seventh Edition

    Out of stock

    Book SynopsisEmbryo research, cloning, assisted conception, neonatal care, pandemic vaccine development, saviour siblings, organ transplants, drug trials – modern developments have transformed the field of medicine almost beyond recognition in recent decades and the law struggles to keep up.In this highly acclaimed and very accessible book Margaret Brazier, Emma Cave and Rob Heywood provide an incisive survey of the legal situation in areas as diverse as fertility treatment, patient consent, assisted dying, malpractice and medical privacy.The seventh edition of this book has been fully revised and updated to cover the latest cases, Brexit-related regulatory reform and COVID-19 pandemic measures.Essential reading for healthcare professionals, lecturers, medical and law students, this book is of relevance to all whose perusal of the daily news causes wonder, hope and consternation at the advances and limitations of medicine, patients and the law.Table of ContentsIntroductionPart I Medicine, law and society1 Law and medicine: lessons from yesterday2 The practice of medicine today3 Doctors’ responsibilities: patient’s rights4 Medicine, moral dilemmas and the Law5 A relationship of trust and confidencePart II Medical malpractice6 Agreeing to treatment7 Competence, consent and compulsion8 Clinical negligence9 Medical litigation10 The criminal process and medical malpractice11 Complaints and redress12 Medical products liabilityPart III Matters of life and death13 Pregnancy14 Abortion15 Embryo research16 Developments in assisted conception17 Doctors and children18 Healthcare research19 Defining death20 Organ and tissue transplantation21 The human body and its parts22 End of lifeBibliographyIndex

    Out of stock

    £102.00

  • Medical Treatment: Decisions and the Law

    Bloomsbury Publishing PLC Medical Treatment: Decisions and the Law

    Out of stock

    Book SynopsisThis leading textbook places medical decision-making in its legal context and provides practical guidance on the most ethically challenging cases that face the courts. It explains how the Mental Capacity Act works in practice and how the courts and lawyers wrestle with and resolve problems relating to the very essence of life: what is life? what is an acceptable quality of life? what treatment is so burdensome that it should not be attempted? These questions are posed, not in the abstract but, in real – often desperate, often urgent – situations. This is the essential guide for solicitors, barristers and judges specialising in Court of Protection work, clinical negligence, personal injury and human rights. Postgraduate medical ethics students and academics, NHS bodies and local authority professionals, health professionals and administrators in the NHS and private practice and those in Commonwealth countries with an interest in these topics will also find this book an invaluable resource. Medical Treatment: Decisions and the Law offers a readily accessible text for those dealing with the provision of medical treatment to those without capacity and related areas, providing a clear description of procedure as well as practical application of the law. Key developments for the Fourth Edition include: · The impact of the Covid-19 pandemic on decision making in the Court of Protection, particularly in relation to end of life decisions and vaccination · New chapters on two controversial issues: “the Right to Die?” and “Access to Healthcare: Choice” · Expanded chapter on Decisions for Children, covering recent high-profile cases such as Re Gard where continued provision of life sustaining treatment for babies or very young infants was at issue, and addressing the difficult issues around decision making by 16 to 17 year olds · Substantially updated chapter on Going to Court, covering how the incapacitous patient can be supported to participate in decisions about their treatment Discussion of “Escalation of Care” covering matters including NICE guidelines and care pathways and expanded coverage of issues concerning the funding of treatment. This title is included in Bloomsbury Professional's Clinical Negligence online service.Trade ReviewAs an authoritative guide to how the law works, and how to navigate the law in medical treatment decision-making, the guide is unrivalled. -- Alex Ruck Keene * Mental Capacity Law and Policy Blog *‘It can rightly claim to be the authoritative practitioner text for medical treatment cases…drawing on the very substantial wealth of experience of the authorial team.’ * Alex Ruck-Keene, Court of Protection barrister *‘A wonderfully user-friendly, quick reference guide…This is a book for practitioners written by practitioners. It is as close to granting the reader a free direct advice-line to counsel as the joint heads of Serjeants’ Inn are ever likely to permit.’ * David Locke in the NLJ *Table of ContentsPart 1: General Principles 1. Consent – general 2. Consent - adults 3. Deciding for others - adults 4. Consent and deciding for others - children 5. Restraint and deprivation of liberty 6. Going to court 7. Access to healthcare - choice 8. Access to healthcare - funding Part 2: Specific Problems 9. Abortion 10. Sterilisation and contraception 11. Assisted reproduction 12. Pregnancy and childbirth 13. Feeding 14. Religious observance and objections to treatment 15. Withdrawal and withholding of treatment 16. The right to die? 17. Treating suicidal patients 18. The end of life 19. Human organ and tissue donation Appendices

    Out of stock

    £189.50

  • Clinical Negligence

    Bloomsbury Publishing PLC Clinical Negligence

    15 in stock

    Book Synopsis"I would highly recommend this book...It is high quality, clear and comprehensive and will no doubt prove an invaluable source of reference. Five stars on all counts." Tim Kevan, co-editor, PIBULJ.COM This book remains the only text of its kind to cover both the medical and legal aspects of medical negligence. Written by a team of more than 60 experts, it continues to provide the most comprehensive and authoritative guidance on all aspects of clinical negligence claims, from bringing an action for damages to presenting expert evidence in court. It also includes detailed consideration of funding and cost implications. Those needing clear guidance to make the best possible preparations for an action will find all they need here. The new 6th edition has been fully revised and restructured, including new chapters on the future of clinical negligence litigation, cardiology, gynaecology, obstetrics, haematology , and also includes coverage and analysis of recent key cases such as: - Williams v Bermuda Hospitals [2016] UKPC 4 (causation) - R (on the application of Maughan) v HM Senior Coroner for Oxfordshire [2020] UKSC 46 (suicide in inquests) - Darnley v Croydon Health Authority [2018] UKSC 50 (duty of care owed by receptionist) - ABC v St George's Hosp [2020] EWHC 455 (Huntington's chorea confidentiality) - Swift v Carpenter [2020] EWCA Civ 1295 (future accommodation costs) - Whittington Hospital NHS Trust v XX [2020] UKSC 14 (damages for surrogacy) - Khan v Meadows [2021] UKSC 21 (scope of duty of care) - Nguyen v HM Assistant Coroner for Inner West London [2021] EWHC 3354 (sufficiency of inquiry) Easy-to-access structure The new edition maintains its easy-to-access, two-part structure. The first part, set out in 16 chapters, deals with legal aspects of medical malpractice, including complaints procedures, poor performance and medical professional governance, preparation of medical evidence, settlements and trial. There are also chapters on product liability, and coronial law. The final 27 chapters in the second part cover the risks associated with particular areas of specialist medical practice. This title is included in Bloomsbury Professional's Clinical Negligence online service.Trade ReviewThere are certain law books that stand out as in a class of their own and this fifth edition of 'Clinical Negligence' stands tall among them... I would highly recommend this book for those practising in this area. It is high quality, clear and comprehensive and will no doubt prove an invaluable source of reference. Five stars on all counts. -- Tim Kevan * PIBULJ.COM *It retains its place as a key guide for practitioners in this area.I have been looking forward to the new edition and am notdisappointed. There is little in the field of clinical negligence that is not at least touched upon and the text either provides useful guidance (procedural or medical) or at least points in the right direction. -- Phillipa Luscumbe, Partner, PI, Penningtons * NLJ March 2016 *Table of ContentsForeword Preface Contributors Table of Statutes Table of Cases Chapter 1 Clinical Negligence Litigation: the Problem, the Solution - the Future? Chapter 2 The Law Chapter 3 Improving Safety, Reducing Harm and Subsequent Claims Chapter 4 The Role of NHS Resolution Chapter 5 Human Rights Chapter 6 Compensation Schemes Chapter 7 Funding Clinical Negligence Claims Chapter 8 The Coroner’s Inquest Chapter 9 The Duties of the Expert Witness and the Medical Expert Reporting Process Chapter 10 The Conduct of Proceedings Chapter 11 Consent Chapter 12 Limitation of Actions Chapter 13 Product Liability for Medical Products Chapter 14 Damages Awards: Lump Sums and Periodical Payments Chapter 15 Causation Chapter 16 Epidemiology and Statistics in Litigation Chapter 17 Negligence in General Practice Chapter 18 Emergency Medicine Chapter 19 Cardiology Chapter 20 Endocrinology Chapter 21 Neurology Chapter 22 Oncology Chapter 23 Psychiatry Chapter 24 Litigation in Clinical Radiology Chapter 25 Ophthalmology Chapter 26 General Surgery Chapter 27 Vascular Surgery Chapter 28 Chronic Pain Chapter 29 Anaesthesia Chapter 30 Neurosurgery Chapter 31 Spinal Surgery Chapter 32 Otolaryngology – Head and Neck Surgery Chapter 33 Orthopaedics Chapter 34 Urological Surgery Chapter 35 Cardiothoracic Surgery Chapter 36 Dental Surgery Chapter 37 Obstetrics Chapter 38 Gynaecology Chapter 39 Neonatology Chapter 40 Imaging for Perinatal and Early Childhood Neurological Problems Chapter 41 Medicolegal Issues in Haematology Index

    15 in stock

    £546.25

  • Intersex Embodiment: Legal Frameworks beyond

    Bristol University Press Intersex Embodiment: Legal Frameworks beyond

    15 in stock

    Book SynopsisThis book examines the divergent medical, political and legal constructions of intersex. The authors use empirical data to explore how intersex people are embodied through these frameworks which in turn influence their lived experiences. Through their analysis, the authors reveal the factors that motivate and influence the way in which policy makers and legislators approach the area of intersex rights. They reflect on the limitations of law as the primary vehicle in challenging healthcare’s framing of intersex as a ‘disorder’ in need of fixing. Finally, they offer a more holistic account of intersex justice which is underpinned by psychosocial support and bodily integrity.Table of Contents1. Introduction 2. Medical Embodiment: Intersex as Disorder 3. Non-Binary Embodiment: Intersex and Third-Gender Markers 4. LGBT Embodiment: Queerness, Homonormativity and Anti-Discrimination Law 5. Engaging with Intersex Experience: Can Law Disrupt Medical Embodiment? 6. Intersex as Acceptance and Emergence: Can Psychosocial Frameworks Disrupt Medical Embodiment? 7. Conclusion: Intersex Embodiment

    15 in stock

    £72.00

  • Capacity, Participation and Values in Comparative

    Bristol University Press Capacity, Participation and Values in Comparative

    15 in stock

    Book SynopsisWith contributions from an international team of experts, this collection provides a much-needed international, comparative approach to mental capacity law. The book focuses particularly on exploring substantive commonalities and divergences in normative orientation and practical application embedded in different legal frameworks. It draws together contributions from eleven different jurisdictions across Europe, Asia and the UK and explores what productive or unproductive values and practices currently exist. By providing a detailed comparison of how legal and ethical commitments to persons with disabilities are framed in capacity law across different national systems, the book highlights the values and practices that could lead to changes that better respect persons with disabilities in mental capacity regimes.Table of Contents1. Introduction: Values, Participation, and Mental Capacity Laws in International Comparative Perspective – Camillia Kong, John Coggon, Penny Cooper, Michael Dunn, Alex Ruck Keene 2. Mental Capacity Law in England and Wales: A Value-Laden Jurisdiction – Rebecca Stickler 3. Mental Capacity Regimes Approach to Values and Participation in Proceedings Involving Individuals With Impaired Decision-Making Capacity in Scotland – Jill Stavert 4. The Fusion Approach to Mental Capacity Law in Northern Ireland: Possibilities and Challenges – Gavin Davidson, Martin Daly, Moira Harper, Danielle McIlroy and Lorna Montgomery 5. Judging Values in a Time of Transition: An Irish Perspective – Mary Donnelly 6. US Laws Relating to Decision-Making on Behalf of P – Stephen Latham 7. Indigenous Peoples With Disabilities and Canadian Mental Capacity Law – Ruby Dhand 8. Capacity, Participation and Values in Australian Guardianship Laws – Cameron Stewart 9. Navigating Values in Aotearoa New Zealand – Kris Gledhill 10. Values and Participation of Individuals Without Mental Capacity in Hong Kong – Daisy Cheung 11. Asian Values and Confucianism: How P’s Ability To Participate in Court Proceedings in Singapore Is Influenced by P’s Cultural Milieu – Yue-En Chong 12. Respect for the Will and Preferences of People With Mental Disorders in German Law – Tanje Henking and Matthé Scholten 13. The Place of Values and P’s Participation in Mental Capacity Law: Themes, Synergies, and Tensions – Camillia Kong, John Coggon, Penny Cooper, Michael Dunn, Alex Ruck Keene

    15 in stock

    £77.34

  • Health Care Use of Electronically Readable Cards:

    Nova Science Publishers Inc Health Care Use of Electronically Readable Cards:

    1 in stock

    Book Synopsis

    1 in stock

    £92.79

  • Private Health Insurance: Factors Affecting

    Nova Science Publishers Inc Private Health Insurance: Factors Affecting

    Out of stock

    Book Synopsis

    Out of stock

    £63.19

  • Abortion in the United States: Judicial History,

    Nova Science Publishers Inc Abortion in the United States: Judicial History,

    Out of stock

    Book Synopsis

    Out of stock

    £78.39

  • The Veterans Choice Program (VCP): Access,

    Nova Science Publishers Inc The Veterans Choice Program (VCP): Access,

    1 in stock

    Book SynopsisIn response to concerns about access to medical care at many Department of Veterans Affairs (VA) hospitals and clinics across the country in Spring 2014,1 Congress passed the Veterans Access, Choice, and Accountability Act of 2014 (VACAA, P.L. 113-146, as amended). On 7 August 2014, President Obama signed the bill into law. Among other things, the act establishes a new program that would allow the VA to authorise care for enrolled veterans through the Veterans Choice Program if they meet the eligibility requirements.

    1 in stock

    £113.59

  • Health Insurance: Requirements, Challenges, and

    Nova Science Publishers Inc Health Insurance: Requirements, Challenges, and

    1 in stock

    Book SynopsisSince 1 January 2014, most individuals have had to maintain health insurance coverage or pay a penalty for noncompliance implemented through the Internal Revenue Code (IRC). To comply with this individual mandate, individuals need to maintain minimum essential coverage, which includes most types of public and private health insurance coverage. A majority of Americans have health insurance from the private health insurance (PHI) market. Health plans sold in the PHI market must comply with requirements at both the state and federal levels; such requirements often are referred to as market reforms. During the Obama Administration, the two federal agencies primarily responsible for administering the private health insurance provisions in the Affordable Care Act (ACA) -- the Centers for Medicare & Medicaid Services (CMS) within the Department of Health and Human Services (HHS), and the Internal Revenue Service (IRS) within the Treasury Department -- took a series of actions to delay, extend, or otherwise modify the laws implementation.

    1 in stock

    £138.39

  • U.S. Drug Supply, Investigational Drugs and

    Nova Science Publishers Inc U.S. Drug Supply, Investigational Drugs and

    1 in stock

    Book SynopsisChapter 1 reports on the U.S. drug supply and the complex way it is interwoven with multiple stakeholders involved in each step of the process. When investigational drugs show promise for treating serious or life-threatening diseases, patients are often interested in obtaining access to them. Congress included a provision in the FDA Reauthorization Act of 2017 for GAO to review actions taken to facilitate access to these drugs. Chapter 2 describes (1) actions FDA and drug manufacturers have taken to broaden eligibility criteria for clinical trials, (2) actions FDA has taken to facilitate access to investigational drugs outside of clinical trials, and (3) information drug manufacturers have communicated to patients and physicians about access to investigational drugs outside of clinical trials. Chapter 3 reports on requiring e-prescriptions for coverage under part D of the Medicare program for prescription drugs that are controlled substances.

    1 in stock

    £163.19

  • Medicaid Politics: Federalism, Policy Durability,

    Georgetown University Press Medicaid Politics: Federalism, Policy Durability,

    Out of stock

    Book SynopsisMedicaid, one of the largest federal programs in the United States, gives grants to states to provide health insurance for over 60 million low-income Americans. As private health insurance benefits have relentlessly eroded, the program has played an increasingly important role. Yet Medicaid's prominence in the health care arena has come as a surprise. Many astute observers of the Medicaid debate have long claimed that "a program for the poor is a poor program" prone to erosion because it serves a stigmatized, politically weak clientele. Means-tested programs for the poor are often politically unpopular, and there is pressure from fiscally conservative lawmakers to scale back the 350-billion-per-year program even as more and more Americans have come to rely on it. For their part, health reformers had long assumed that Medicaid would fade away as the country moved toward universal health insurance. Instead, Medicaid has proved remarkably durable, expanding and becoming a major pillar of America's health insurance system. In "Medicaid Politics", political scientist Frank J. Thompson examines the program's profound evolution during the presidential administrations of Bill Clinton, George W. Bush, and Barack Obama and its pivotal role in the epic health reform law of 2010. This clear and accessible book details the specific forces embedded in American federalism that contributed so much to Medicaid's growth and durability during this period. It also looks to the future outlining the political dynamics that could yield major program retrenchment.Trade ReviewThe book provides an excellent analysis of the Medicaid program, while strengthening understanding of the broader questions regarding how the policy process works. Choice For anyone wishing to gain deeper insight into Medicaid policy or how policy is made in instances of cooperative federalism, Medicaid Politics is a worthwhile read... it offers a thorough explanation of policy history and sheds light on the processes behind creating Medicaid policy since 1993 [and] presents a good sense of the trade-offs in policy decisions and the details of implementation. Publius Any collection strong in Medicaid and health care reform processes will find this invaluable. Midwest Book ReviewTable of Contents1. Medicaid and the Health Care Crucible 2. Dodging the Block Grant Bullet and Other Signs of Resilience 3. Beyond Welfare Medicine: The Take-Up Challenge 4. Government by Waiver: The Quest to Transform Long-Term Care 5. Demonstration Waivers and the Politics Of Reinvention 6. Reform: The Politics of Polarization 7. Durability, Federalism, and the Future of Medicaid Appendixes 1. Medicaid Expenditures 2. Medicaid Enrollees 3. Medicaid Provisions of Key Debt Reduction Plans References Index

    Out of stock

    £26.55

  • The Case of Terri Schiavo: Ethics at the End of

    Prometheus Books The Case of Terri Schiavo: Ethics at the End of

    Out of stock

    Book SynopsisAfter the Nancy Cruzan case was decided by the Supreme Court in 1990, and ultimately resolved by the Courts of the State of Missouri, the decision to withhold or withdraw life-prolonging nutrition and hydration appeared to many to be as noncontroversial as decisions to refuse respirators or dialysis. Even the Catholic Church held that, although there should be a presumption in favor of providing nutrition and hydration, the patient or the patient's surrogate could overrule this presumption, if either believed the treatment was disproportionate or burdensome. The Schiavo case changed all that. Although the decision to remove Terri Schiavo's nutrition and hydration was made by her husband - her legal surrogate - based on his wife's belief that such treatment was disproportionate, Schiavo's immediate family protested so much that the case took years to resolve. It eventually involved all branches of government at both the state and federal levels. The ethical dilemmas that such cases pose continue to stir great controversy. This in-depth examination of these dilemmas provides information and documentation from many perspectives. The editors have included a foreword by Dr. Jay Wolfson, Terri Schiavo's court-appointed guardian ad litem, as well as Dr. Wolfson's report to Gov. Jeb Bush on the case and Gov. Bush's reply; public statements by President George Bush and Senators David Weldon, Rick Santorum, Tom DeLay, Bill Frist, and Barney Frank; statements by the pope and other representatives of the Catholic Church on this issue; plus much medical and legal background material on both precedents to the Schiavo case and its aftermath, including the results of the autopsy report. For anyone wishing an in-depth understanding of these complex ethical issues, issues many of us will have to confront in our own families, this volume is indispensable.

    Out of stock

    £15.29

  • How Medicaid Fails the Poor

    Encounter Books,USA How Medicaid Fails the Poor

    3 in stock

    Book SynopsisMedicaid, America's government-run health insurance program for the poor, should be a lifeline that provides needed health care to Americans with no other options. Surprisingly, however, it doesn't. The medical literature reveals a $450 billion-a-year scandal: that people on Medicaid have far worse health outcomes than those with private insurance, and no better outcomes than those with no insurance at all. Why is this so? In How Medicaid Fails the Poor, Avik Roy explains how Medicaid's clumsy design and perverse incentives make it hard for people on Medicaid to get the medical care they need. Medicaid doesn't reimburse doctors or hospitals for the cost of caring for Medicaid enrollees, forcing many doctors to opt out of the program. The Affordable Care Act, otherwise known as Obamacare, doubles down on this broken system. Roy shows us that there are better ways, using private insurance, to provide needed care to our poorest citizens.

    3 in stock

    £6.40

  • Patient Protection & Affordable Care Act: Select

    Nova Science Publishers Inc Patient Protection & Affordable Care Act: Select

    1 in stock

    Book Synopsis

    1 in stock

    £106.49

  • Indian Health Care: Improvement Act & Health

    Nova Science Publishers Inc Indian Health Care: Improvement Act & Health

    2 in stock

    Book Synopsis

    2 in stock

    £46.49

  • ABA Medical-Legal Guides: The Spine for Lawyers

    American Bar Association ABA Medical-Legal Guides: The Spine for Lawyers

    Out of stock

    Book SynopsisInjuries involving the spine are the most common compensation claims in the United States. ABA Medical-Legal Guides: The Spine for Lawyers is designed to help practitioners, judges and insurance professionals understand the multifaceted medical and legal issues in a claim involving this part of the human anatomy. Containing more than 200 illustrations and photos, The Spine is an indespensable guide to understanding the medical issues facing your clients.

    Out of stock

    £151.99

  • Becoming an Expert Witness in Health Care and

    SLACK Incorporated Becoming an Expert Witness in Health Care and

    1 in stock

    Book SynopsisA resource for healthcare professionals in beginning, improving, or successfully marketing a career as an expert witness, Becoming an Expert Witness in Healthcare and Litigation: A Beginner's Guide provides fundamental information on the legal process and practical advice for readers across various fields of medicine and allied health.The book draws on the authors’ experiences as both expert witnesses and litigation experts who have trained hundreds of nurses, physicians, and healthcare professionals. Covering topics like the fundamentals of litigation and the legal process and trial preparation, Becoming an Expert Witness in Healthcare and Litigation explores the basic principles of being an expert witness while offering practical advice that will enable expert witnesses and attorneys to maximize their effectiveness.Topics covered include:•Roles and expectations of key players•Courtroom presentation•Depositions and trials•Moral issues•Writing for the court•Business of expert witnessing•Ethical marketingAlso included in Becoming an Expert Witness in Healthcare and Litigation:•Checklists•Example expert witness forms like fee structures, engagement letters, and more•A comprehensive glossary of industry termsThose looking to break into the field and seasoned expert witnesses alike will find that Becoming an Expert Witness in Healthcare and Litigation: A Beginner's Guide offers valuable insights and guidance.Table of Contents Dedication Acknowledgments About the Authors Preface Foreword by Eric F. Quandt, JD Chapter 1 What Is an Expert? Chapter 2 Qualifications of an Expert Chapter 3 The Role of an Expert Chapter 4 Preparation for Expert Opinions Chapter 5 Disclosure of Opinions, Basis, and Bias Chapter 6 Presentation of Opinions Chapter 7 Conflicts of Interest Chapter 8 Establishing a Fee Structure Chapter 9 Expert Promotion Chapter 10 Dos and Don’ts of an Expert Glossary Bibliography Index

    1 in stock

    £49.40

  • Abortion Law in the United States & Europe

    Nova Science Publishers Inc Abortion Law in the United States & Europe

    1 in stock

    Book Synopsis

    1 in stock

    £67.99

  • Affordable Care Act: Analyses of Emergent Issues

    Nova Science Publishers Inc Affordable Care Act: Analyses of Emergent Issues

    1 in stock

    Book Synopsis

    1 in stock

    £63.74

  • Small Business & the Affordable Care Act

    Nova Science Publishers Inc Small Business & the Affordable Care Act

    1 in stock

    Book Synopsis

    1 in stock

    £122.99

  • Physician Law: Evolving Trends and Hot Topics:

    American Bar Association Physician Law: Evolving Trends and Hot Topics:

    Out of stock

    Book SynopsisPhysicians Law: Evolving Trends & Hot Topics 2015 was produced in conjunction with the Chicago Medical Society and the American Medical Association and is specifically tailored to an audience that includes physicians, lawyers, and healthcare administrators along with business healthcare affiliates. This incomparable health law resource includes eight peer-reviewed chapters on core physician-centric legal topics: * Entrepreneurial Medicine (including fraud and abuse risk areas) * Physician-Hospital Contracting * Medical Professional Liability * Telemedicine * HIPAA * Accountable Care Organizations * Peer Review: Physician Plaintiffs and Medical Staff Members * Physician Well-Being

    Out of stock

    £79.19

  • Law, Medicine, and Medical Technology, Cases and

    West Academic Publishing Law, Medicine, and Medical Technology, Cases and

    2 in stock

    Book SynopsisFive years after publication of the third edition, and reflecting the dynamic nature of the pharmaceutical and medical device industries (as well as the many different areas of law that pertain to the management of these medical technologies), the Fourth Edition incorporates the latest legislative, regulatory, and judicial developments, describes recent scientific advances, and excerpts or references new scholarly contributions to this broad field (the wealth of citations should facilitate use in a seminar setting). Measured by volume, more than 20% of the previous edition has been replaced with new material. The latest edition retains the same basic thematic approach and modular structure of the original, which allows instructors to pick and choose the materials to cover based on their own tastes and areas of expertise.

    2 in stock

    £211.50

  • Public Reporting of Health Care Performance

    Nova Science Publishers Inc Public Reporting of Health Care Performance

    1 in stock

    Book Synopsis

    1 in stock

    £131.19

  • Medicaid Prescription Drugs: Pricing & Policy

    Nova Science Publishers Inc Medicaid Prescription Drugs: Pricing & Policy

    1 in stock

    Book Synopsis

    1 in stock

    £131.19

  • Medicare Part D Prescription Drug Benefit:

    Nova Science Publishers Inc Medicare Part D Prescription Drug Benefit:

    1 in stock

    Book Synopsis

    1 in stock

    £131.19

  • Health Insurance Affordability & the Role of

    Nova Science Publishers Inc Health Insurance Affordability & the Role of

    1 in stock

    Book Synopsis

    1 in stock

    £67.99

  • Shortages of Drugs Containing Controlled

    Nova Science Publishers Inc Shortages of Drugs Containing Controlled

    1 in stock

    Book Synopsis

    1 in stock

    £131.19

  • Health Benefits for Federal Employees & Members

    Nova Science Publishers Inc Health Benefits for Federal Employees & Members

    1 in stock

    Book Synopsis

    1 in stock

    £131.19

  • Patient Dumping: Background, Protections, & the

    Nova Science Publishers Inc Patient Dumping: Background, Protections, & the

    1 in stock

    Book Synopsis

    1 in stock

    £131.19

  • Medicaid Fraud Control: Integrity Efforts in

    Nova Science Publishers Inc Medicaid Fraud Control: Integrity Efforts in

    2 in stock

    Book SynopsisMedicaid is a significant expenditure for the federal government and the states, with total federal outlays of $310 billion in fiscal year 2014. The Centers for Medicare & Medicaid Services (CMS) reported an estimated $17.5 billion in potentially improper payments for the Medicaid program in 2014. This book identifies and analyses indicators of improper or potentially fraudulent payments in fiscal year 2011, and examines the extent to which federal and state oversight policies, controls, and processes are in place to prevent and detect fraud and abuse in determining eligibility.

    2 in stock

    £67.99

  • Health Care in the United States: Developments &

    Nova Science Publishers Inc Health Care in the United States: Developments &

    1 in stock

    Book Synopsis

    1 in stock

    £135.19

  • Individual Mandate & Premium Tax Credits in the

    Nova Science Publishers Inc Individual Mandate & Premium Tax Credits in the

    1 in stock

    Book Synopsis

    1 in stock

    £120.79

  • Prescription Drugs & the DEA: Interactions &

    Nova Science Publishers Inc Prescription Drugs & the DEA: Interactions &

    1 in stock

    Book Synopsis

    1 in stock

    £120.79

  • Health Care Costs: Policies, Economics & Outcomes

    Nova Science Publishers Inc Health Care Costs: Policies, Economics & Outcomes

    1 in stock

    Book Synopsis

    1 in stock

    £120.79

  • Key Issues Facing Medicaid

    Nova Science Publishers Inc Key Issues Facing Medicaid

    1 in stock

    Book Synopsis

    1 in stock

    £120.79

  • Private Health Insurance & Essential Health

    Nova Science Publishers Inc Private Health Insurance & Essential Health

    1 in stock

    Book Synopsis

    1 in stock

    £63.19

  • Connected Health Care: A Roadmap for

    Nova Science Publishers Inc Connected Health Care: A Roadmap for

    1 in stock

    Book Synopsis

    1 in stock

    £120.79

  • U.S. Health Care Workforce: Supply & Demand

    Nova Science Publishers Inc U.S. Health Care Workforce: Supply & Demand

    1 in stock

    Book Synopsis

    1 in stock

    £138.39

  • Congressional Actions Interfering with the

    Nova Science Publishers Inc Congressional Actions Interfering with the

    Out of stock

    Book Synopsis

    Out of stock

    £92.79

  • What Is...The Anti-Kickback Statute? Second

    American Bar Association What Is...The Anti-Kickback Statute? Second

    3 in stock

    Book SynopsisThe federal Anti-Kickback Statute (AKS) is one of the best-known federal fraud and abuse statutes, due largely to its wide-ranging effects on business relationships in the health care, pharmaceutical, and medical device sectors. The newly-updated second edition of this primer explains how AKS is a criminal statute that prohibits transactions intended to induce or reward referrals for items or services reimbursed by the federal health care programs. It further details the anti-corruption statute and how it is designed to protect federal health care program beneficiaries from the influence of money on referral decisions and thus is intended to guard against overutilization, increased costs, and poor quality services.

    3 in stock

    £51.02

  • Physician Law: Evolving Trends & Hot Topics 2022

    American Bar Association Physician Law: Evolving Trends & Hot Topics 2022

    3 in stock

    Book SynopsisThis book represents the cutting edge of physician law. The publication emanates from the American Bar Association Health Law Section’s 2022 Physicians Legal Issues Conference. The conference and Physician Law: Evolving Trends & Hot Topics have been produced in conjunction with the Chicago Medical Society and the American Medical Association, tailored to an audience including physicians, lawyers, healthcare administrators, and other healthcare business people. The book includes ten peer-reviewed chapters on core physician-centric legal topics: 1) Entrepreneurial Medicine (including fraud and abuse risk areas); 2) Physician-Hospital Contracting; 3) Medical Professional Liability; 4) Telemedicine; 5) HIPAA Compliance; 6) Accountable Care Organizations; 7) Doctors’ Defense in Medical Staff Hearings and Appeals; 8) Physician Well-Being; 9) Medicare and Medicaid Contractors; and 10) Physician Employment Contracts from the Physician Perspective. Physicians will especially benefit from the content that addresses a broad range of non-clinical topics that are currently transforming American healthcare. The chapters target issues that are not typically covered in most medically oriented volumes but nonetheless are critically important in the practice of medicine. Physician Law: Evolving Trends & Hot Topics is an excellent reference for clinicians and professionals who want to stay abreast of current legal and regulatory issues impacting their practice.

    3 in stock

    £107.55

  • The Right to Health of the Child: An Analytical

    Intersentia Ltd The Right to Health of the Child: An Analytical

    Out of stock

    Book SynopsisWorldwide, children face significant health risks. The right to health of the child offers insight into the ways in which these risks should be mitigated. However, the concept of 'the highest attainable standard of health of the child' as laid down in article 24 of the Convention on the Rights of the Child remains unclear. Therefore, this book seeks to clarify the international normative framework on the right to health of the child. It does so by looking at the international children's rights framework, international health and human rights law and by taking a particular look at relevant legislation in the European region, covering both European Union legislation and human rights law of the Council of Europe, including the Guidelines on Child-Friendly Healthcare. Also, the interpretation of the right to health by the UN Committee on the Rights of the Child is analyzed for 35 countries of different levels of development. On the basis of these sources, priorities are identified that should be realized to achieve the highest attainable standard of health of the child. This book addresses the question how the implementation process influences the interpretation of the highest attainable standard of health of the child. This results in a definition of the highest attainable standard of health of the child that takes into account the varying capabilities of individual children and which considers children as active rights-holders, notwithstanding their age or level of development.Table of ContentsCONTENTS Acknowledgements List of Abbreviations I. Introduction 1.1. Introduction 1.2. Problem statement and research questions 1.2.1. Research question 1.3. Methodology 1.3.1. Theoretical framework: the capability approach 1.3.2. Relating the capability approach to the highest attainable standard of health 1.3.3. Research methodology 1.4. Definition of health 1.4.1. Relevance of a definition of health 1.4.2. In search of a definition of health 1.5. Health as a right 1.6. Focus on the provision of primary health care 1.7. Children and vulnerability 1.7.1. Definition of the child 1.7.2. Definition of vulnerability 1.7.3. Empowerment 1.8. Outline of the PhD study II. The Right to Health of the Child in the Children's Rights Convention 39 2.1. Introduction 2.2. Historical development of the right to health of the child in the CRC 2.3. Key elements of the right to health of the child in the CRC 2.3.1. Substance of article 24 CRC 2.3.2. Provisions on implementation of article 24 CRC 2.4. The right to health and its relation to other CRC articles 2.4.1. Article 2: The right to non-discrimination 2.4.1.1. Forbidden ground for discrimination 2.4.1.2. Violation of the right to health 2.4.1.3. Protection of a certain interest 2.4.2. Article 3: The best interests of the child 2.4.3. Article 6: The right to life, survival and development 2.4.4. Article 12: The right of the child to be heard 2.4.5. The dilemma between protection and children's autonomy 2.4.6. Articles 5 & 18: The role of the parents in ensuring their children's health 2.4.7. Articles 26 & 27: Social security and an adequate standard of living 2.4.8. Partial conclusion 2.5. Interpretation of the child's right to health in the General Comments 2.5.1. General Comment 3: HIV/AIDS and the rights of the child 2.5.2. General Comment 4: Adolescent health and development 2.5.3. General Comment 7: Children's rights in early childhood 2.5.4. General Comment 9: The rights of children with disabilities 2.5.5. General Comment 11: Indigenous children and their rights under the Convention 2.5.6. General Comment 12: The right of the child to be heard 2.5.7. General Comment 13: The right of the child to freedom of all forms of violence 2.5.8. The newly adopted General Comment 15 on children's right to health 2.5.8.1. Holistic approach to health 2.5.8.2. Active involvement of all stakeholders 2.5.8.3. Primary health care 2.5.8.4. Reduction of infant and child mortality 2.5.9. Concluding observations on the General Comments 2.6. The basic principles of medical ethics from a children's rights perspective 2.7. Conclusion 2.7.1. Priorities in interpreting the right to the health of the child 2.7.2. Responsible actors III. Children's Right to Health in the Recommendations of the Committee on the Rights of the Child in the Concluding Observations on the Country Reports 3.1. Introduction 3.2. The reporting procedure on basic health and welfare in the Country Reports 3.3. Research method 3.4. Results I: Explanation of children's right to have access to health care in the Concluding Observations of the CRC Committee 3.4.1. Access as a prerequisite for realizing the highest attainable standard of health 3.4.2. Access to health care for vulnerable children 3.5. Results II: Systematically recurring recommendations on the right of the child to the highest attainable standard of health in the Concluding Observations 3.5.1. Lack of data in developing and developed countries 3.5.2. Budget allocation for the implementation of economic, social and cultural rights 3.5.3. Training on children's rights for professionals in the health sector 3.5.4. Birth registration as a prerequisite for social security and access to health care 3.5.4.1. Recommendations for countries categories in groups II-IV 3.5.5. Standard of living 3.5.6. Primary health care infrastructure 3.5.7. Children affected by armed conflict 3.5.8. Emerging themes 3.6. Results III: Different standards for the implementation of children's right to health for countries with different levels of human development? 3.6.1. Implementation of the right to health of the child in different circumstances and regions 3.6.2. Access to health care for children in developing and developed countries 3.6.3. Priorities set for developing and for developed countries 3.7. Conclusion and recommendations 3.7.1. Identified priorities in interpreting the right to the highest attainable standard of health 3.7.2. Relating the CRC framework to the Concluding Observations of the Committee 3.7.3. Recommendations to the CRC Committee IV. The Right to Health of the Child in International Health and Human Rights Law: Adding a Human Voice? 4.1. Introduction 4.2. An analysis of the key sources on children's right to health in international health law 4.2.1. The right to health in the UDHR, ICESCR, WHO Constitution 4.2.2. The right to health of the child in international health law 4.3. Key features of the right to health of the child in international health law 4.3.1 Availability 4.3.2. Accessibility 4.3.2.1. No de iure and de facto discrimination 4.3.2.2. Economic accessibility 4.3.2.3. Physical accessibility 4.3.2.4. Information accessibility 4.3.2.5. Organizational accessibility 4.3.3. Acceptability 4.3.4. Quality 4.4. Patient involvement as a key constituent element of the right to health 4.5. A synthesis 4.6. Key features of a health system for children based on the right to health 4.7. Conclusion V. Regional Interpretations of the Right to Health of the Child: a Focus on Europe 5.1. Introduction 5.2. Universalism in a local context 5.2.1. Universalism and the right to health of the child 5.3. Children's right to health in Europe 5.3.1. The right to health of the child in the European Union 5.3.2. The EU strategy on the rights of the child in Europe 5.3.3. The WHO strategy on the rights of the child in Europe 5.3.4. The role of children in ensuring the highest attainable standard of health of the child in the European Union 5.3.5. The role of families in ensuring the highest attainable standard of health of the child 5.3.6. The role of medical professionals 5.4. The interpretation of the right to health of the child by the Council of Europe 5.4.1. Interpretation of the right to health of the child in the European Social Charter 5.4.2. The Biomedical Convention 5.4.3. Key health issues in the Recommendations of the Council of Europe 5.4.4. The European Convention on Human Rights 5.5. Child-friendly health care: a step forward? 5.5.1. The guidelines on child-friendly healthcare: a focus on children and their families 5.5.2. Key elements of child-friendly health care 5.5.3. Practical relevance of the guidelines 5.5.4. The Charter of the European Association on Children's Rights 5.5.5. Relation between the EACH Charter and the Guidelines on Child-Friendly Health Care 5.6. Conclusion 5.6.1. The margin of appreciation on children's right to health in Europe 5.6.2. Focus on prevention of health problems 5.6.3. Child-centred health care 5.6.4. Family friendly health care 5.6.5. Empowerment 5.6.6. Discussion VI. Realizing the Right to Health of the Child 6.1. Introduction 6.2. Children's right to health and the social reality in which children live 6.3. The role of the state in realizing the right to health of children 6.3.1. The right to health of children: realizing economic, social, cultural rights 6.3.2. 'Available resources' 6.3.3. Appropriate measures 6.3.3.1. Within a reasonable time 6.3.3.2. Reasonable program 6.3.4. Justiciability of children's right to health in domestic courts 6.3.4.1. Application of the right to health in Dutch domestic law cases 6.3.4.2. Judicial and quasi-judicial decision-making 6.3.5. International cooperation for ensuring the right to health of the child 6.4. Responsibilities for non-state actors to contribute to realizing the right to the highest attainable standard of health of the child 6.4.1. The involvement of children in the medical process 6.4.2. The responsibilities of parents 6.4.3. The role of medical professionals in realizing children's right to health 6.5. Optional Protocol III to the CRC on a communications procedure for children 6.5.1. Drafting history 6.5.2. Exhaustion of national remedies 6.5.3. Children's rights in Optional Protocol III: room for participation? 6.6. Conclusion: how can the highest attainable standard of health of the child, i.e. child-centred health-care be realized? VII. Conclusions 7.1. Priorities set to achieve the highest attainable standard of health of the child 7.1.1. Priorities set in the children's rights domain 7.1.2. Priorities set in international health and human rights law 7.1.3. Priorities set in European human rights law 7.1.4. The highest attainable standard of health is a moving target 7.2. Realizing the right to the highest attainable standard of health 7.2.1. Children as rights-holders: empowerment 7.2.2. The role of the State in realizing the right to health of the child 7.2.2.1. Effective remedies 7.2.2.2. International cooperation 7.2.3. Actors responsible in the process of implementation 7.2.3.1. Parents 7.2.3.2. Medical professionals 7.3. Children's right to health: a living reality References Curriculum vitae Summary Samenvatting

    Out of stock

    £67.45

  • Preventing Medical Malpractice and Compensating

    Intersentia Ltd Preventing Medical Malpractice and Compensating

    Out of stock

    Book SynopsisPreventing Medical Malpractice and Compensating Victimised Patients in China is the first book in English on the legal remedies for preventing medical errors and compensating victims of medical malpractice in China from an economic and legal perspective. Specifically, those legal remedies include tort liability, regulation, insurance and social security. The new medical liability regime based on the Tort Liability Law 2009 currently provides the primary legal remedy against medical malpractice. However, the role of alternative regimes in medical quality assurance and victim compensation should not be ignored. This book:- gives a full description of all the current legal remedies for the prevention of medical malpractice and compensation for iatrogenic injuries in China, in order to see how those different legal instruments interact with and impact on one another.- examines how those legal remedies work in practice and what impact they have on society, based on an extensive analysis of court decisions, several semi-structured interviews, and a review of the available empirical literature.- summarises the law and economics studies on medical malpractice and applies economic theories to the legal remedies in China, in order to put forward policy recommendations to China.The ultimate conclusion of this work is that although many aspects of the legal remedies in China are consistent with the economic model of accident law as far as the prevention of medical malpractice is concerned, they still need great improvement when it comes to compensation for iatrogenic injuries.Overall, this book provides a thorough examination and evaluation of the legal remedies for medical malpractice in China, especially taking into account the latest developments in economic theories and new empirical findings. Hence, it will be of interest to legal and economic scholars, students, lawyers, insurers and policy makers responsible for ensuring the quality of medical care.

    Out of stock

    £135.85

  • Free Movement of Patients in the Eu: A Patient's

    Intersentia Ltd Free Movement of Patients in the Eu: A Patient's

    Out of stock

    Book SynopsisThe issues of patient mobility have been high on the EU's political agenda for the last two decades. However, the adoption of the Patient Mobility Directive, which had to be implemented by the Member States until 25 October 2013, added to the complexity of an already complex legislative system. Thus both, the new questions raised by the new piece of legislation and the old questions left without satisfactory answers call for new solutions. So particularly at a time, when the national application of the Directive is beginning to have an impact on border-crossing patients it is imperative to revisit patient mobility. However, in contrast to the existing literature, Free Movement of Patients in the EU tests the current legal landscape from the perspective of border-crossing patients. How, in a multi-player arena of patients, healthcare providers, healthcare funds, national governments, Union institutions, etc. with colliding ideologies can the legal situation be improved in a way that better serves patients' interests while respecting the responsibilities of the Member States in this field and with the legal tools currently available? This book is of interest to scholars and practicing experts dealing with patient mobility or social security issues as well as stakeholders and decision-makers. [Subject: Medical Law, EU Law]

    Out of stock

    £75.05

  • Competition Policy in Healthcare: A Comparative

    Intersentia Ltd Competition Policy in Healthcare: A Comparative

    Out of stock

    Book SynopsisThis book examines competition policy (competition law, merger control and sectoral regulation) in English and Dutch healthcare. In contrast to the United States, competition in English and Dutch healthcare develops from the principle of universal access to healthcare, which appears antithetical to competition. Unsurprisingly, competition reforms in both a health insurance system (the Netherlands) and a taxation-funded National Health Service (NHS) (England) have proved controversial. Such reforms are also proving difficult to implement, with both countries developing “healthcare-specific” modifications of general competition rules and differing relationships between the competition authorities and healthcare regulators in applying these. This book challenges both existing literature and the policy underpinning the reforms by adopting the position that healthcare is fundamentally different to other liberalized sectors and thus requires special treatment. Furthermore, it argues that different approaches are needed to accommodate the specific characteristics of national healthcare systems (such as the tension between the NHS and private healthcare in the UK) within the wider typology of insurance-based and taxation-funded systems across Europe. It also provides a first context-based comparative law study in this area. This analysis is timely in light of ongoing criticism of the reforms and current refocusing of competition within healthcare in both countries.Trade Review'[...] this volume offers very interesting reading that is not limited to these two jurisdictions, moreover, for health law academics and practitioners more generally, as well. It is not a coincidence that the author is a member of the European Association of Health Law.' -- Herman Nys, Professor emeritus of health law, KU Leuven, Belgium; Editor-in-Chief, European Journal of Health Law, 2019.Table of ContentsIntroduction (p. 1). Chapter 1. Competition Reforms in Dutch and English Healthcare and the Development of Competition Policy (p. 19). Chapter 2. Competition Law: Its Applicability and Application in Dutch and English Healthcare (p. 61). Chapter 3. Sectoral Regulation: The Relationship between the Competition Authority and the Healthcare Regulator in the Netherlands and England (p. 115). Chapter 4. Merger Control: Hospital Mergers, General Merger Control and the Development of 'Healthcare-Specific' Merger Control in the Netherlands and England (p. 161). Conclusion (p. 215).

    Out of stock

    £75.05

  • Economics of Health Law

    Edward Elgar Publishing Ltd Economics of Health Law

    7 in stock

    Book SynopsisRonen Avraham, David Hyman and Charles Silver, leading authorities in their fields, discuss the effects of economic and legal constraints and regulation on healthcare. They examine the impact of access to healthcare on mortality and clinical outcomes and investigate healthcare financing, including payment to providers, expanding costs, health insurance and the provision of long-term care. The distribution of spending and the expansion of provision are also investigated. The regulatory aspect includes discussions on the regulation of healthcare practice, medical malpractice and liability, and public health and ethical issues.Table of ContentsContents: Volume I Introduction Ronen Avraham, David A. Hyman and Charles M. Silver PART I ACCESS TO HEALTHCARE: HEALTHCARE, MORTALITY AND OTHER CLINICAL OUTCOMES 1. Andrew P. Wilper, Steffie Woolhandler, Karen E. Lasser, Danny McCormick, David H. Bor and David U. Himmelstein (2009), ‘Health Insurance and Mortality in US Adults’, American Journal of Public Health, 99 (12), December, 2289–95 2. Richard Kronick (2009), ‘Health Insurance Coverage and Mortality Revisited’, HSR: Health Services Research, 44 (4), August, 1211–31 3. Katherine Baicker, Sarah L. Taubman, Heidi L. Allen, Mira Bernstein, Jonathan H. Gruber, Joseph P. Newhouse, Eric C. Schneider, Bill J. Wright, Alan M. Zaslavsky and Amy N. Finkelstein (2013), ‘The Oregon Experiment – Effects of Medicaid on Clinical Outcomes’, New England Journal of Medicine, 368 (18), May 2, 1713–22 PART II FINANCING HEALTH CARE A Payment Structure and Incentives 4. Ching-to Albert Ma and Thomas G. McGuire (1997), ‘Optimal Health Insurance and Provider Payment’, American Economic Review, 87 (4), September, 685–704 5. Sherry Glied and Joshua Graff Zivin (2002), ‘How Do Doctors Behave When Some (But Not All) of Their Patients are in Managed Care?’, Journal of Health Economics, 21 (2), March, 337–53 6. Thomas L. Greaney (2009), ‘Economic Regulation of Physicians: A Behavioral Economics Perspective’, Saint Louis University Law Journal, 53, 1189–209 7. Austin B. Frakt (2011), ‘How Much Do Hospitals Cost Shift? A Review of the Evidence’, Milbank Quarterly, 89 (1), March, 90–130 B Cost Drivers 8. Joseph P. Newhouse (1992), ‘Medical Care Costs: How Much Welfare Loss?’, Journal of Economic Perspectives, 6 (3), Summer, 3–21 9. Burton A. Weisbrod (1991), ‘The Health Care Quadrilemma: An Essay on Technological Change, Insurance, Quality of Care, and Cost Containment’, Journal of Economic Literature, XXIX (2), June, 523–52 10. Einer Elhauge (1997), ‘The Limited Regulatory Potential of Medical Technology Assessment’, Virginia Law Review, 82, 1525–617 C Health Insurance 11. Kenneth J. Arrow (1963), ‘Uncertainty and the Welfare Economics of Medical Care’, American Economic Review, LIII (5), December, 941–73 12. Mark V. Pauly (1968), ‘The Economics of Moral Hazard’, American Economic Review, 58 (3), Part I, June, 531–7 13. Kenneth J. Arrow (1968), ‘The Economics of Moral Hazard: Further Comment’, American Economic Review, 58 (3), Part 1, June, 537–9 14. Katherine Baicker and Amitabh Chandra (2008), ‘Myths and Misconceptions about U.S. Health Insurance’, Health Affairs, 27 (6), October, w533–w543, content.healthaffairs.org, accessed 13 August 2013 15. Sherry A. Glied (2005), ‘The Employer-Based Health Insurance System: Mistake or Cornerstone?’, in David Mechanic, Lynn B. Rogut, David C. Colby and James R. Knickman (eds), Policy Challenges in Modern Health Care, Chapter 3, Piscataway, NJ: Rutgers University Press, 37–52 D Moral Hazard and Adverse Selection 16. John A. Nyman (2004), ‘Is “Moral Hazard” Inefficient? The Policy Implications of a New Theory’, Health Affairs, 23 (5), September–October, 194–9 17. David M. Cutler and Sarah J. Reber (1998), ‘Paying for Health Insurance: The Trade-off between Competition and Adverse Selection’, Quarterly Journal of Economics, 113 (2), May, 433–66 E Long-Term Care 18. Mark V. Pauly (1990), ‘The Rational Nonpurchase of Long-Term-Care Insurance’, Journal of Political Economy, 98 (1), February, 153–68 19. Jeffrey R. Brown and Amy Finkelstein (2011), ‘Insuring Long-Term Care in the United States’, Journal of Economic Perspectives, 25 (4), Fall, 119–41 and ‘Appendix: Calculating Loads and Comprehensiveness’, http://www.aeaweb.org/articles.php?doi=10.1257/jep.25.4.119. Accessed 25.02.2014, 1-13 PART III DISTRIBTUTION OF SPENDING AND CROWD-OUT 20. Katherine Baicker, Amitabh Chandra and Jonathan S. Skinner (2005), ‘Geographic Variation in Health Care and the Problem of Measuring Racial Disparities’, Perspectives in Biology and Medicine, 48 (1), Supplement, Winter, S42–S53 21. Tomas J. Philipson, Seth A. Seabury, Lee M. Lockwood, Dana P. Goldman and Darius N. Lakdawalla (2010), ‘Geographic Variation in Health Care: The Role of Private Markets’ and ‘Comment and Discussion’, Brookings Papers on Economic Activity, Spring, 325–55, 56–61 22. David M. Cutler and Jonathan Gruber (1996), ‘Does Public Insurance Crowd out Private Insurance?’, Quarterly Journal of Economics, 111 (2), May, 391–430 PART IV COMPETITION AND FRAGMENTATION IN THE HEALTH CARE INDUSTRY 23. David Hyman (2010), ‘Health Care Fragmentation: We Get What We Pay For’, in Einer Elhauge (ed.), Fragmentation of U.S. Health Care: Causes and Solutions, Chapter 2, Oxford, UK: Oxford University Press, 23–36 24. Thomas (Tim) Greaney (2009), ‘Competition Policy and Organizational Fragmentation in Health Care’, University of Pittsburgh Law Review, 71 (2), 217–39 Index Volume II Contents: An introduction to both volumes by the editors appears in Volume I PART I REGULATION OF HEALTH CARE PRACTICE A Drugs and Devices 1. Anup Malani and Tomas Philipson (2012), ‘The Regulation of Medical Products’, in Patricia Danzon and Sean Nicholson (eds), Oxford Handbook of the Economics of the Biopharmaceutical Industry, Chapter 5, Oxford, UK: Oxford University Press, 100–42 2. Michelle M. Mello, Sara Abiola and James Colgrove (2012), ‘Pharmaceutical Companies’ Role in State Vaccination Policymaking: The Case of Huyman Papillomavirus Vaccination’, American Journal of Public Health, 102 (5), May, 893–8 B Licensure and Guidelines 3. Ronen Avraham (2011), ‘Clinical Practice Guidelines – The Warped Incentives in the U.S. Healthcare System?’, American Journal of Law and Medicine, 37 (1), Spring, 7–40 4. Shirley Svorny (1993), ‘Advances in Economic Theories of Medical Licensure’, Federation Bulletin: The Journal of Medical Licensure and Discipline, 80 (1), Spring, 27–32 C Provider Rankings 5. Peter K. Lindenauer, Denise Remus, Sheila Roman, Michael B. Rothberg, Evan M. Benjamin, Allen Ma and Dale W. Bratzler (2007), ‘Public Reporting and Pay for Performance in Hospital Quality Improvement’, New England Journal of Medicine, 356 (5), February, 486–96 6. David Dranove, Daniel Kessler, Mark McClellan and Mark Satterthwaite (2003), ‘Is More Information Better? The Effects of “Report Cards” on Health Care Providers’, Journal of Political Economy, 111 (3), June, 555–88 PART II MEDICAL MALPRACTICE AND LIABILITY 7. Richard A. Epstein (1976), ‘Medical Malpractice: The Case for Contract’, American Bar Foundation Research Journal, 1 (1), 87–149 8. Jennifer Arlen (2013), ‘Economic Analysis of Medical Malpractice Liability and Its Reform’, in Jennifer Arlen (ed.), Research Handbook on the Economics of Tort, Chapter 2, Cheltenham, UK and Northampton, MA, USA: Edward Elgar Publishing Ltd, 33–69 9. Kenneth S. Abraham and Paul C. Weiler (1994), ‘Enterprise Medical Liability and the Evolution of the American Health Care System’, Harvard Law Review, 108 (2), December, 381–436 10. Kathryn Zeiler, Bernard S. Black, Charles Silver, David A. Hyman and William M. Sage (2008), ‘Physicians’ Insurance Limits and Malpractice Payments: Evidence from Texas Closed Claims, 1990-2003’, Journal of Legal Studies, 36 (S2), June, S9–S45 11. David M. Studdert, Michelle M. Mello, Atul A. Gawande, Tejal K. Gandhi, Allen Kachalia, Catherine Yoon, Ann Louise Puopolo and Trojen A. Brennan (2006), ‘Claims, Errors, and Compensation Payments in Medical Malpractice Litigation’, New England Journal of Medicine, 354 (19), May, 2024–33 12. Daniel Kessler and Mark McClellan (1996), ‘Do Doctors Practice Defensive Medicine?’, Quarterly Journal of Economics, 111 (2), May, 353–90 13. Daniel P. Kessler (2011), ‘Evaluating the Medical Malpractice System and Options for Reform’, Journal of Economic Perspectives, 25 (2), Spring, 93–110 14. Ronen Avraham, Leemore S. Dafny and Max M. Schanzenbach (2012), ‘The Impact of Tort Reform on Employer-Sponsored Health Insurance Premiums’, Journal of Law Economics and Organization, 28 (4), October, 657–86 15. Janet Currie and W. Bentley MacLeod (2008), ‘First Do No Harm? Tort Reform and Birth Outcomes’, Quarterly Journal of Economics, 123 (2), May, 795–830 PART III PUBLIC HEALTH A Infections and Antibiotic Resistance 16. Ramanan Laxminarayan and Anup Malani (2011), ‘Economics of Infectious Diseases’, in Sherry Glied and Peter C. Smith (eds), Oxford Handbook of Health Economics, Chapter 9, Oxford, UK: Oxford University Press, 189–205 17. William M. Sage and David A. Hyman (2010), ‘Combatting Antimicrobial Resistance: Regulatory Strategies and Institutional Capacity’, Tulane Law Review, 84 (4), March, 781–840 B Obesity 18. Ronen Avraham and K.A.D. Camara (2007), ‘The Tragedy of Human Commons’, Cardozo Law Review, 29 (2), November, 479–511 [33] 19. Tomas Philipson (2001), ‘The World-Wide Growth in Obesity: An Economic Research Agenda’, Health Economics, 10, 1–7 20. Tomas J. Philipson and Richard A. Posner (2008), 'Is the Obesity Epidemic a Public Health Problem? A Review of Zoltan J. Acs and Alan Lyles's Obesity, Business and Public Policy', Journal of Economic Literature, 46 (4), December, 974–82 PART IV ETHICAL ISSUES 21. Ezekiel J. Emanuel and Margaret P. Battin (1998), ‘What are the Potential Cost Savings from Legalizing Physician-Assisted Suicide?’, New England Journal of Medicine, 339 (3), July, 167–72 22. Judd B. Kessler and Alvin E. Roth (2012), ‘Organ Allocation Policy and the Decision to Donate’, American Economic Review, 102 (5), August, 2018–47 23. Jason Snyder (2010), ‘Gaming the Liver Transplant Market’, Journal of Law, Economics, and Organization, 26 (3), December, 546–68 Index

    7 in stock

    £534.85

© 2025 Book Curl

    • American Express
    • Apple Pay
    • Diners Club
    • Discover
    • Google Pay
    • Maestro
    • Mastercard
    • PayPal
    • Shop Pay
    • Union Pay
    • Visa

    Login

    Forgot your password?

    Don't have an account yet?
    Create account